Welcome to the e-CCO Library!

P332: Group-based Acceptance and Commitment Therapy (ACT) is acceptable and effective at reducing psychological distress in patients with Inflammatory Bowel Disease (IBD).
Year: 2022
Source: ECCO'22
Authors: Duff, A.(1);De Petrillo, A.(2);Reynolds, D.(3);Bangura, E.(4);Pavilidis, P.(1);Mawdsley, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
P332: Influence of mesalamine maintenance therapy on progression of ulcerative proctitis in Korea
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. S. Choi1, W. J. Kim*2, H.-J. Jung3, J. K. Kim1, K.-H. Song3

Created: Friday, 22 February 2019, 9:49 AM
P332: Multinational comparisons of practices in overseas travel in Crohn’s disease and ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Greveson*1, C. Inglis2, S. Ben-Horin3, S. Ghaly4, Y. Yunki5, R. Leong5

Created: Friday, 22 February 2019, 9:41 AM
P332: Population pharmacokinetics of ozanimod and active metabolite CC112273 in patients with ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Shen, J.(1);Tatosian, D.(1);Sid-Otmane, L.(2);Teuscher, N.(3);Chen, L.(1);Zhang, P.(1);Tirucherai, G.S.(1);Chitakara, D.(1);Marta, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P332: Treat to target in Crohn's disease: ultrasonographic response is associated with better outcomes
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zorzi F., Lolli E., Onali S., Petruzziello C., Fantini M.C., Biancone L., Monteleone G., Calabrese E.

Created: Wednesday, 20 February 2019, 10:36 AM
P333 Biologic longevity: Withdrawal of drugs due to remission is rare in clinical practice
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Sharma, G. Cunningham, P. Dawson, F. D’Errico, S. Honap, S. Lim, R. Luber, S. Meade, P. Pavlidis, R. Reynolds, P. Irving

Created: Thursday, 30 January 2020, 10:12 AM
P333: Associations between multiple immunosuppressive treatments before surgery and surgical morbidity in patients with ulcerative colitis during the era of biologics
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Uchino*1, H. Ikeuchi1, T. Bando1, T. Chohno1, H. Sasaki1, Y. Horio1, R. Kuwahara1, T. Minagawa1, Y. Goto1

Created: Friday, 22 February 2019, 9:41 AM
P333: Changing patterns of biological therapy use with the introduction of biosimilars in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mortier K.1, Arnott I.*2, Russell R.K.3 UK Inflammatory Bowel Disease (IBD) Audit Steering Group

Created: Wednesday, 20 February 2019, 10:36 AM
P333: Early intestinal ultrasound remission is associated with endoscopic healing after one year of infliximab therapy in Crohn's disease: a multicentre prospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Revés, J.(1)*;Morão, B.(1);Nascimento, C.(1);Frias-Gomes, C.(1);Cúrdia Gonçalves, T.(2);Freitas, M.(2);Castro, F.(2);Moreira, M.J.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Sousa, R.(3);Coelho, R.(4);Macedo, G.(4);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
Created: Friday, 14 July 2023, 11:05 AM
P333: Endoscopic severity and CRP predict failure of medical rescue therapy in patients with acute severe ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Kakkadasam Ramaswamy, P.(1);Subhaharan, D.(1);Willmann, L.(1);Edwards, J.(1);Shukla, D.(1);Bhullar, M.(1);Moattar, H.(1);Dorrington, A.(1);Ishaq, N.(1);McIvor, C.(2);Mohsen, W.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P333: Long-term efficacy and safety of thiopurines in patients with steroid-dependent ulcerative colitis: a retrospective investigation
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. Yokoyama*, T. Sato, M. Kawai, Y. Kita, K. Kamikozuru, T. Miyazaki, M. Iimuro, N. Hida, S. Nakamura

Created: Friday, 22 February 2019, 9:49 AM
P333: Precise and unbiased infliximab dosing in patients with inflammatory bowel diseases using a multi-model averaging approach
Year: 2022
Source: ECCO'22
Authors: Kantasiripitak, W.(1);Outtier, A.(2,3);Thomas, D.(1);Kensert, A.(1);Wang, Z.(1);Sabino, J.(2,3);Wicha, S.G.(4);Vermeire, S.(2,3);Ferrante, M.(2,3);Dreesen, E.(1);
Created: Friday, 11 February 2022, 3:52 PM
P333: The baseline features of patients with newly diagnosed moderate-to-severe ulcerative colitis in Korea: A population-based cohort study (the MOSAIK cohort)
Year: 2018
Source: ECCO '18 Vienna
Authors:

S.J. Oh1*, J.R. Moon1, C.K. Lee1, Y.M. Park1, S.N. Hong2, J.P. Im3, B.D. Ye4, J.M. Cha1, S.-A. Jung5, K.-M. Lee6, D.I. Park7, Y.T. Jeen8, Y.S. Park9, J.H. Cheon10, H.-S. Kim11, Y. Kim11, H.J. Kim1, H.J. Kim1, the IBD research group of the Korean Association for the Study of Intestinal Diseases

Created: Thursday, 21 February 2019, 9:14 AM
P334 Impact of disease duration on tofacitinib efficacy in patients with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Travis1, I. Dotan2, S. Danese3, M. Chiorean4, J. Yamamoto-Furusho5, D. Ponce de Leon6, C. Su7, J. Paulissen8, E. Maller7, I. Modesto9, J.F. Colombel10

Created: Thursday, 30 January 2020, 10:12 AM
P334: Chromoendoscopy is superior to white light endoscopy for the detection of advanced colonic neoplasia in patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. O. Kim*1,2, M. Chiorean2

Created: Friday, 22 February 2019, 9:41 AM
P334: Does the circadian clock have a role in the pathogenesis of inflammatory bowel disease (IBD)?
Year: 2018
Source: ECCO '18 Vienna
Authors:

Y. Weintraub1*, S. Cohen1, I. Dotan2,3, R. Tauman3,4, N. Chapnik5, O. Froy5

Created: Thursday, 21 February 2019, 9:14 AM
P334: Effectiveness and safety of ustekinumab in Crohn’s disease: short and long-term results of a multi-refractory cohort.
Year: 2022
Source: ECCO'22
Authors: Aparicio-Serrano, A.(1);Zamora Olaya, J.M.(1);Ortiz Chimbo, D.S.(1);Rodríguez Tirado, M.I.(1);Gómez Pérez, A.(1);Soto Escribano, P.(1);Marín Pedrosa, S.(1);Iglesias Flores, E.(1);Benítez, J.M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P334: Evolution of a long-term follow-up cohort of Crohn’s disease with complex perianal fistula: from antibiotic to combined AZA and anti-TNF based treatment ending up clinical and radiological healing with or without stoma
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. Erzin*, K. Ercaliskan, I. Hatemi, K. Atay, S. Bozcan, N. Demir, A. F. Celik

Created: Friday, 22 February 2019, 9:49 AM
P334: Medication adherence in diverse inner city pediatric patients with inflammatory bowel disease and comparison to physician perception of adherence
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ferreira J., Thomas S., Tomer G.

Created: Wednesday, 20 February 2019, 10:36 AM
P334: Respiratory Manifestations and Association Between Disease Activity in Patients with Inflammatory Bowel Disease in a Reference Center in Salvador, Bahia, Brazil.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fortes, F.(1,2)*;Gonçalves, J.(3);Nery, E.(4);Arenas, L.(4);Mota, J.(1);Pimentel, A.(1);Almeida, N.(5);Santos, A.M.(3);Surlo, V.(5);Santana, G.(4);
Created: Friday, 14 July 2023, 11:05 AM